Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioSig Technologies Inc BSGM

Healthcare Medical Devices
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is... see more

Recent & Breaking News (NDAQ:BSGM)

Manasi Patwardhan Joins BioSig as Director of Strategic Planning

GlobeNewswire July 11, 2019

BioSig Technologies, Inc. Added to Membership of Russell 3000® Index

GlobeNewswire July 1, 2019

Samuel E. Navarro Appointed to BioSig Board of Directors

GlobeNewswire June 25, 2019

BioSig Technologies Issues June 2019 Shareholder Letter

GlobeNewswire June 20, 2019

BioSig Technologies Set to Join Russell 3000® Index

GlobeNewswire June 10, 2019

BioSig Allowed a U.S. Patent for PURE EP(TM) Simulator

GlobeNewswire June 6, 2019

BioSig Technologies Receives $4.6 Million in Cash Warrant and Option Exercises

GlobeNewswire June 3, 2019

BioSig Technologies to Present at the 9th Annual LD Micro Invitational

GlobeNewswire May 30, 2019

BioSig Allowed First Key US Patent Claims for its PURE EP(TM) System

GlobeNewswire May 23, 2019

Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors

GlobeNewswire May 20, 2019

BioSig Technologies Completes Patient Cases at Indiana University

GlobeNewswire May 6, 2019

BioSig's Manuscript Accepted to IEEE Engineering in Medicine and Biology Conference 2019

GlobeNewswire May 2, 2019

BioSig To Participate at Heart Rhythm Society's Scientific Sessions 2019

GlobeNewswire April 30, 2019

Frank J. Quintero Joins BioSig Technologies Advisory Board

GlobeNewswire April 9, 2019

D.A. Wallach Joins BioSig Technologies Advisory Board

GlobeNewswire March 26, 2019

BioSig Technologies Completes Private Placement

GlobeNewswire March 14, 2019

BioSig Technologies to Present at the LD Micro Virtual Conference

GlobeNewswire March 8, 2019

BioSig Technologies to Present at the 31st Annual ROTH Conference

GlobeNewswire March 7, 2019

BioSig Appoints Barry Keenan as Vice President of Engineering

GlobeNewswire March 6, 2019

Is This MedTech Start-Up The Next Hundred-Billion Cardio Breakthrough Stock?

Press Releases March 5, 2019